In a preclinical study, researchers at Children's Hospital of Philadelphia (CHOP) demonstrated a novel gene therapy with potentially increased effectiveness and safety for the treatment of ...
A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug ...
Pseudomyxoma peritonei is a rare and poorly understood cancer, characterized by the progressive accumulation of mucin in the abdominal cavity. Mainstay treatments are surgery and chemotherapy but ...
A new study from RCSI University of Medicine and Health Sciences demonstrates a novel approach in anticancer vaccine development. Results present the first preclinical evidence to show the efficacy of ...
A new meta-analysis suggests that CBD may improve emotional behavior and cognition in animal models, but researchers caution ...
FGF21 is primarily known as a metabolic hormone. A new study by researchers at Helmholtz Munich and Ludwig Maximilians University has described a previously unknown mechanism through which FGF21 ...
Early findings from a new preclinical study indicate that dual blockade of aurora-A kinase and PD-L1 signaling can inhibit tumor growth in triple-negative breast cancer (TNBC), treatment for which has ...
Early results from solid tumor model support additional studies in pancreatic and colorectal cancer models; full dataset planned for presentation later in 2026SAN DIEGO, June 01, 2026 (GLOBE NEWSWIRE) ...
A new study has found for the first time that magnetoelectric nanoparticles—tiny, wirelessly controlled particles activated by magnetic fields—can both locate and destroy pancreatic tumors in ...
An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumors, according to a new study. The preclinical study combined the analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results